TOXIC ALGAL BLOOMS MAY BE KEY TO SLOWING NEURODEGENERATIVE DISEASE
URI – Kingston Rhode Island (October 28, 2019) More medicines may be developed faster in the near future, thanks to new technology that harnesses the tiny particles that make drug
NEW TECHNOLOGY ACCESSES SMALL BUT MIGHTY MICROORGANISMS
News USA (October 9, 2019) – 11|KTVA More medicines may be developed faster in the near future, thanks to new technology that harnesses the tiny particles that make drug development possible.
Dr. John Ryals added to the Biosortia Pharmaceutical Board of Directors
San Diego, California (September 10, 2019)/PRNewswire/ – Biosortia, a leader in the next frontier of drug discovery, accessing the enormous chemical and genomic potential of natural microbiomes, is pleased to announce
UNLOCKING TREASURED CHEMISTRY OF HOW NATURE HEALS TO IMPROVE HUMAN HEALTH
Columbus, OH Ohio University Presentation (November 9, 2018)
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms
Columbus, OH (October 28, 2018) – Journal of Natural Products Biosortia Demonstrated Products Aquatic microbiomes contain novel chemistry. Novel chemistry previously undetectable & inaccessible. Biosortia has proven capability of accessing previously
Microcystins Containing Doubly Homologated Tyrosine Residues from a Microcystis aeruginosa Bloom: Structures and Cytotoxicity
American Chemical Society and American Society of Pharmacognosy (May 30, 2018) Four new microcystin congeners are described including the first three examples of microcystins containing the rare doubly homologated
LEIDOS AND BIOSORTIA PHARMACEUTICALS EXECUTE MEMORANDUM OF UNDERSTANDING
RESTON, VA (Aug. 14, 2017) – Leidos (LDOS) (NYSE: LDOS), a FORTUNE 500 science and technology company, has signed a Memorandum of Understanding (MOU) with Biosortia Pharmaceuticals to explore creating a
MICROBIOME, HIDDEN CHEMICAL SECRETS, BEING ACCESSED AT SCRIPPS PIER IN SAN DIEGO
Biosortia Pharmaceuticals is utilizing unique technologies to obtain the chemistry of previously unstudied microorganisms for drug discovery San Diego, California (November 8, 2016) – Biosortia Pharmaceuticals Inc. announces today that it
Reduce Risks and Increase Revenues by Building Platforms
Columbus, OH (May 16, 2016) – Ross Youngs is the person behind the US Department of Energy R&D project that led to the development of Biosortia’s drug discovery platform. The platform
SEARCHING FOR CANCER TREATMENTS IN HARMFUL ALGAL BLOOMS
Columbus, OH (May 02, 2016) – A new collaboration by researchers at Ohio State, Nationwide Children’s Hospital, and Biosortia Pharmaceuticals will explore the potential for cancer treatments in compounds harvested from